Mr. Oram has more than 30 years of experience in healthcare and biotechnology companies. He has previously served as president of Orthologic and executive vice president of the Musculoskeletal Transplant Foundation.
Bone Biologics is developing a proprietary protein for use in bone regenerative medicine using the patented recombinant human protein known as UCB-1.
More articles on devices:
North American spine surgery market in 5 years: 8 things to know
Can ozone gas fix leg pain from disc herniation? 5 quick facts Triojection System’s first try
The Asia Pacific’s rising importance for the total joint market: 8 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
